BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24587953)

  • 1. Cross-reactivity to Acetaminophen and Celecoxib According to the Type of Nonsteroidal Anti-inflammatory Drug Hypersensitivity.
    Kim YJ; Lim KH; Kim MY; Jo EJ; Lee SY; Lee SE; Yang MS; Song WJ; Kang HR; Park HW; Chang YS; Cho SH; Min KU; Kim SH
    Allergy Asthma Immunol Res; 2014 Mar; 6(2):156-62. PubMed ID: 24587953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.
    Asero R
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):554-8. PubMed ID: 10400483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children.
    Kidon MI; Kang LW; Chin CW; Hoon LS; See Y; Goh A; Lin JT; Chay OM
    Pediatrics; 2005 Nov; 116(5):e675-80. PubMed ID: 16230465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs.
    Doña I; Blanca-López N; Jagemann LR; Torres MJ; Rondón C; Campo P; Gómez AI; Fernández J; Laguna JJ; Rosado A; Blanca M; Canto G
    Allergy; 2011 Nov; 66(11):1428-33. PubMed ID: 21834936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
    Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema.
    Kowalski ML; Woessner K; Sanak M
    J Allergy Clin Immunol; 2015 Aug; 136(2):245-51. PubMed ID: 26254051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of patients with nonaspirin-exacerbated respiratory disease aspirin hypersensitivity reactions.
    Saff RR; Banerji A
    Allergy Asthma Proc; 2015; 36(1):34-9. PubMed ID: 25562554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral drug challenges in non-steroidal anti-inflammatory drug-induced urticaria, angioedema and anaphylaxis.
    Chaudhry T; Hissaria P; Wiese M; Heddle R; Kette F; Smith WB
    Intern Med J; 2012 Jun; 42(6):665-71. PubMed ID: 21981353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drug hypersensitivity among children.
    Guvenir H; Dibek Misirlioglu E; Vezir E; Toyran M; Ginis T; Civelek E; Kocabas CN
    Allergy Asthma Proc; 2015; 36(5):386-93. PubMed ID: 26314820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.
    Morales DR; Lipworth BJ; Guthrie B; Jackson C; Donnan PT; Santiago VH
    J Allergy Clin Immunol; 2014 Jul; 134(1):40-5. PubMed ID: 24388008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance to celecoxib in patients with a history of adverse reactions to nonsteroidal anti-inflammatory drugs.
    Roll A; Wüthrich B; Schmid-Grendelmeier P; Hofbauer G; Ballmer-Weber BK
    Swiss Med Wkly; 2006 Oct; 136(43-44):684-90. PubMed ID: 17183430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancies in the diagnosis and classification of nonsteroidal anti-inflammatory drug hypersensitivity reactions in children.
    Arikoglu T; Aslan G; Yildirim DD; Batmaz SB; Kuyucu S
    Allergol Int; 2017 Jul; 66(3):418-424. PubMed ID: 27865769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of nonsteroidal anti-inflammatory drugs in patients with aspirin hypersensitivity : safety of cyclo-oxygenase-2 inhibitors.
    Kowalski ML; Makowska J
    Treat Respir Med; 2006; 5(6):399-406. PubMed ID: 17154669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Updates in Understanding NSAID Hypersensitivity.
    Minaldi E; Cahill K
    Curr Allergy Asthma Rep; 2023 Mar; 23(3):181-188. PubMed ID: 36757490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetyl Salicylic Acid Challenge in Children with Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs Differentiates Between Cross-Intolerant and Selective Responders.
    Blanca-López N; Haroun-Diaz E; Ruano FJ; Pérez-Alzate D; Somoza ML; Vázquez de la Torre Gaspar M; Rivas-Ruiz F; García-Martin E; Blanca M; Canto G
    J Allergy Clin Immunol Pract; 2018; 6(4):1226-1235. PubMed ID: 28986120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria.
    Asero R
    J Allergy Clin Immunol; 2003 May; 111(5):1095-8. PubMed ID: 12743575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs.
    Campo P; Ayuso P; Salas M; Plaza MC; Cornejo-García JA; Doña I; Torres MJ; Blanca-López N; Canto G; Guéant JL; Sanak M; Blanca M
    Allergy; 2013 Aug; 68(8):1001-7. PubMed ID: 23889565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):154-8. PubMed ID: 16136765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs according to the latest classification.
    Demir S; Olgac M; Unal D; Gelincik A; Colakoglu B; Buyukozturk S
    Allergy; 2015 Nov; 70(11):1461-7. PubMed ID: 26173603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
    Klaewsongkram J; Buranapraditkun S; Mongkolpathumrat P; Palapinyo S; Chantaphakul H
    Allergy Asthma Immunol Res; 2021 Mar; 13(2):229-244. PubMed ID: 33474858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.